• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

INTERVENTION OF AUTOANTIBODY IN THE MEMBRANE PHOSPHOLIPID FLIP-FLOP OF TROPHOBLAST CELLS.

Research Project

Project/Area Number 13670239
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Experimental pathology
Research InstitutionRESEARCH INSTITUTE, OSAKAMEDICAL CENTER FOR MATERNAL AND CHILD HEALTH

Principal Investigator

WADA Yoshinao  RESEARCH INSTITUTE, OSAKAMEDICAL CENTER FOR MATERNAL AND CHILD HEALTH, DEPARTMENT OF MOLECULAR MEDICINE, DIRECTOR, 代謝部門, 部長 (00250340)

Project Period (FY) 2001 – 2002
KeywordsANTIPHOSPHOLIPD ANTIBODY / PHOSPHATIDYLSERINE / THROMBOSIS / COMPLEMENT / FACTOR H
Research Abstract

Antiphospholipid antibody is an autoantibody associated with antiphospholipid syndrome (APS) representing arterial and venous thrombosis, thrombocytopenia, and recurrent fetal loss. The underlying mechanism of these complications is not fully understood, while they are obviously due to accelerated coagulation. Since a negatively charged phospholipid, phosphatidylserine, which potentially triggers blood coagulation, is exposed to the outer leaflet of plasma membrane during apoptosis and trophoblast differentiation, we focused on the proteins binding to negatively charged phospholipids in order to delineate the pathogenesis of APS. An affinity column, in which cardiolipin or phosphatidylserine was embedded in octyl cellulose was prepared, and the plasma proteins bound to these phospholipids were collected by elution with 2M NaCl. A proteins were separated by iD or 2D electrophoresis, and then identified by peptide mass fingerprinting. The proteins included beta2 glycoprotein I, inter-alpha-trypsin inhibitor family heavy chain-related protein (IHRP), complement factor 4, factor H and factor H-related protein I. The binding of factor H was interesting, since factor H mutations cause hemolytic uremic syndrome with characteristic pathology of renal microvascular thrombosis, which also occurs in APS. Recently, the crucial role of alternative complement pathway activation has been reported. Thus, possible involvement of factor H, a regulatory protein of alternative pathway, would be an attractive speculation to delineate the pathogenesis of APS.

  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] 和田芳直, 坂本真由美: "抗リン脂質抗体の新しい分子病態論に向けて"大阪府立母子保健総合医療センター雑誌. 17. 54-61 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 和田芳直: "Annual Review免疫2004"中外医学社. 315(7) (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wada Y, Sakamoto M: "New insight into the molecular pathology of anti phospholipid syndrome"Journal of Osaka Medical Center & Research institute for Maternal & Child Health. 17. 54-61 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wada Y.: "Exposure of phosphatidylserin and complements"in Annual Review Immunology 2004 (Eds. Okumura, Hirano, Satou) (Chugaiigakusha, Tokyo.). 277-283

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi